Every other year in February, the world of oceanography descends upon a conference center somewhere in the world to talk science, showcase innovations and network. It is a chance to see and be seen ...
BOSTON, June 13, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced that data on ...
WALTHAM, Mass.--(BUSINESS WIRE)--Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced a scientific poster presentation highlighting ATACs ...
DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and type 2 diabetes (T2D). Agonism of GPR119 in ...
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results